title: Severity of heart failure, treatments, and outcomes after fibrinolysis in patients with ST-elevation myocardial infarction.
authors.affiliation: Department of Internal Medicine, Rochester General Hospital, Rochester, NY, USA.
authors.forename: Amir
authors.initials: A
authors.lastname: Kashani
authors.forename: Robert P
authors.initials: RP
authors.lastname: Giugliano
authors.forename: Elliott M
authors.initials: EM
authors.lastname: Antman
authors.forename: David A
authors.initials: DA
authors.lastname: Morrow
authors.forename: C Michael
authors.initials: CM
authors.lastname: Gibson
authors.forename: Sabina A
authors.initials: SA
authors.lastname: Murphy
authors.forename: Eugene
authors.initials: E
authors.lastname: Braunwald
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000368:Aged; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D002303:Cardiac Output, Low / Q000188:drug therapy* / Q000209:etiology / Q000401:mortality; D018572:Disease-Free Survival; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy*; D015912:Thrombolytic Therapy / Q000379:methods*; D016896:Treatment Outcome
chemical_list: D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors